Weyes Blood is searching for a way through the dark times

  • 📰 i newspaper
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 89%

Entertainment Entertainment Headlines News

Entertainment Entertainment Latest News,Entertainment Entertainment Headlines

Weyes Blood is searching for a way through the dark times 🟠 Katiesol writes on Weyes Blood's latest offering.

’s fifth album sounds a bit like the end of the world. Every song is woven of layer upon layer of music that has more than a little of the wrath of the heavens about it, rich pealing chorals and strings that dissolve into synths. Each track is like a mini epic, brimming over as she sings in a way that feels desperate and repentant.

The Californian, whose real name is Natalie Mering, seems concerned with the tiny light glowing in the dark: the songs on this album all seem busy and chaotic but there is always a moment of clarity to them, even if that is at the very end – like on “Hearts Aglow”, which flutters into a harp strum after six minutes of searching for hope in a crumbling world.

There’s something monstrous about the sheer wall of sound Weyes Blood has built on this record: the feeling of being closed in on by the music, which echoes the feeling of being bombarded by bad news at every turn .

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 8. in ENTERTAİNMENT

Entertainment Entertainment Latest News, Entertainment Entertainment Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using 68Ga-Pentixafor PETIn recent years, molecular imaging addressing the C-X-C motif chemokine receptor 4 (CXCR4) has increasingly been used in various clinical settings. Here, we aimed to assess radiopharmaceutical uptake and image contrast to determine the most relevant clinical applications for CXCR4-directed imaging. We also investigated the impact of specific activity on scan contrast. Methods: Patients ( n=690) with a variety of neoplasms underwent a total of 777 PET/CT scans with 68Ga-Pentixafor, serving as the CXCR4-specific radioligand. A semiquantitative target lesion analysis was conducted (providing SUVmax and target-to-blood pool ratio [TBR], defined as SUVmax [from target lesion] divided by SUVmean [from blood pool]). The applied specific activity (in MBq/μg) was compared with semiquantitative assessments. Results: Of the 777 scans, 242 did not show discernible uptake in disease sites, leaving 535 PET scans (68.9%) for further analysis. Very high tracer uptake (SUVmax | 12) was found in multiple myeloma ( n=113), followed by adrenocortical carcinoma ( n=30), mantle cell lymphoma ( n=20), adrenocortical adenoma ( n=6), and small cell lung cancer ( n=12). Providing information on image contrast, comparable results for TBR were recorded, with TBR (|8) in multiple myeloma, mantle cell lymphoma, and acute lymphoblastoid leukemia ( n=6). When comparing specific activity with semiquantitative parameters, no significant correlation was found for SUVmax or TBR ( P ≥ 0.612). Conclusion: In this large cohort, 68Ga-Pentixafor demonstrated high image contrast in a variety of neoplasms, particularly for hematologic malignancies, small cell lung cancer, and adrenocortical neoplasms. The present analysis may provide a roadmap for detecting patients who may benefit from CXCR4-targeted therapies.
Source: medical_xpress - 🏆 101. / 51 Read more »